Evidence map›Paper›PMID 19521511›Full record

ArticlePLoS computational biology2009

The dynamics of T-cell receptor repertoire diversity following thymus transplantation for DiGeorge anomaly.

Stanca M Ciupe, Blythe H Devlin, M Louise Markert, Thomas B Kepler

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in PLoS computational biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01220531 nacompletednot on this mapstarted 2010, after this paper: background citation

Safety and Efficacy of Thymus Transplantation in Complete DiGeorge Anomaly, IND#9836

TypeinterventionalSponsorSumitomo Pharma Switzerland GmbHRan2010 to 2023Enrolled29ConditionsComplete DiGeorge Anomaly, DiGeorge Syndrome, DiGeorge Anomaly, Complete DiGeorge SyndromeArmsCultured Thymus Tissue
NCT02274662 phase4completednot on this mapstarted 2014, after this paper: background citation

Expanded Access Protocol Thymus Transplantation for Immunodeficiency, Hematologic Malignancies, and Autoimmune Disease Related to Poor Thymic Function

TypeinterventionalSponsorSumitomo Pharma Switzerland GmbHRan2014 to 2023Enrolled11ConditionsPoor Thymic Function, Immunodeficiency, Athymia, ImmunoreconstitutionArmsCultured Thymus Tissue, Blood Draw, Rabbit Anti-Thymocyte Globulin and Cyclosporine or Tacrolimus
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Experience with cultured thymus tissue in 105 children.The Journal of allergy and clinical immunology · 2022
    Article
  5. Article
  6. Article
  7. How many TCR clonotypes does a body maintain?Journal of theoretical biology · 2016
    Article
  8. Review
  9. Review
  10. Article
  11. Modeling rejection immunity.Theoretical biology & medical modelling · 2012
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Stanca M CiupeCenter for Computational Immunology, Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA.
Blythe H Devlin
M Louise Markert
Thomas B Kepler
Duke Medical Center · USDuke University · US

Funding

THYMIC TRANSPLANTATION IN COMPLETE DIGEORGE SYNDROMER01AI047040 · NIAID · DUKE UNIVERSITY · PI MARKERT, M. LOUISE · 1999 to 2014
$8.0M
Dynamics of TCR Repertoire Following Thymus TransplantR01AI054843 · NIAID · DUKE UNIVERSITY · PI MARKERT, M. LOUISE · 2004 to 2008
$1.9M
Dose Study of thymus TransplantationR01FD002606 · FDA · DUKE UNIVERSITY · PI MARKERT, MARY LOUISE · 2005 to 2007
$934k
FDA HHS FD-R-002606NCRR NIH HHS M03 RR60NIAID NIH HHS R01 AI047040NIAID NIH HHS R01 AI054843NIAID NIH HHS R01 AI 47040NIAID NIH HHS R01 AI 54843
6 · The paper itself

Abstract

T cell populations are regulated both by signals specific to the T-cell receptor (TCR) and by signals and resources, such as cytokines and space, that act independently of TCR specificity. Although it has been demonstrated that disruption of either of these pathways has a profound effect on T-cell development, we do not yet have an understanding of the dynamical interactions of these pathways in their joint shaping of the T cell repertoire. Complete DiGeorge Anomaly is a developmental abnormality that results in the failure of the thymus to develop, absence of T cells, and profound immune deficiency. After receiving thymic tissue grafts, patients suffering from DiGeorge anomaly develop T cells derived from their own precursors but matured in the donor tissue. We followed three DiGeorge patients after thymus transplantation to utilize the remarkable opportunity these subjects provide to elucidate human T-cell developmental regulation. Our goal is the determination of the respective roles of TCR-specific vs. TCR-nonspecific regulatory signals in the growth of these emerging T-cell populations. During the course of the study, we measured peripheral blood T-cell concentrations, TCRbeta V gene-segment usage and CDR3-length spectratypes over two years or more for each of the subjects. We find, through statistical analysis based on a novel stochastic population-dynamic T-cell model, that the carrying capacity corresponding to TCR-specific resources is approximately 1000-fold larger than that of TCR-nonspecific resources, implying that the size of the peripheral T-cell pool at steady state is determined almost entirely by TCR-nonspecific mechanisms. Nevertheless, the diversity of the TCR repertoire depends crucially on TCR-specific regulation. The estimated strength of this TCR-specific regulation is sufficient to ensure rapid establishment of TCR repertoire diversity in the early phase of T cell population growth, and to maintain TCR repertoire diversity in the face of substantial clonal expansion-induced perturbation from the steady state.

Indexed as

Models, ImmunologicalModels, StatisticalAlgorithmsDiGeorge SyndromeHomeostasisHumansLymphocyte CountReceptors, Antigen, T-CellThymus GlandT-LymphocytesReceptors, Antigen, T-Cell

Identifiers

PMID19521511
PMCPMC2690399
OpenAlexW2064173421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.